Systematic review proposes inflammaging as shared driver of osteoporosis and cognitive decline via bone-brain axis
This systematic review synthesizes evidence linking chronic low-grade inflammation (inflammaging) driven by senescent cells to concurrent skeletal aging and cognitive impairment. The authors propose that SASP-derived cytokines and inflammatory pathways (NF-κB, NLRP3) simultaneously drive bone resorption and neuroinflammation through the bone-brain axis, and discuss candidate interventions including senolytics, though they explicitly note most mechanisms rest on preclinical models or single cohorts lacking independent human validation.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 4, 2026 · Discovered: Sep 20, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Systematic review
- Sample size
- —
- Duration
- —
- Population
- Older adults with co-prevalent osteoporosis and cognitive impairment
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- Frontiers in immunology
- Published
- Sep 4, 2026
Sources
Primary source
- Frontiers in immunology ↗Peer reviewed
Assessment history
9/24/2026 · SUPERSEDED: Source updated; assessment withdrawn pending review.
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.